NOL4 | Nucleolar protein 4 | | | | | | Tissue enhanced |
MAPRE2 | Microtubule-associated protein, RP/EB family, member 2 | Plasma proteins
| | | | | Expressed in all |
ZNF24 | Zinc finger protein 24 | Transcription factors
| | | | | Expressed in all |
INO80C | INO80 complex subunit C | Predicted membrane proteins
| | | | | Expressed in all |
GALNT1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
RPRD1A | Regulation of nuclear pre-mRNA domain containing 1A | | | | | | Expressed in all |
SLC39A6 | Solute carrier family 39 (zinc transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ELP2 | Elongator acetyltransferase complex subunit 2 | Predicted secreted proteins
| | | | | Expressed in all |
TPGS2 | Tubulin polyglutamylase complex subunit 2 | | | | | | Expressed in all |
PIK3C3 | Phosphatidylinositol 3-kinase, catalytic subunit type 3 | Enzymes
| | | | | Expressed in all |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
PSTPIP2 | Proline-serine-threonine phosphatase interacting protein 2 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | Disease related genes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HAUS1 | HAUS augmin-like complex, subunit 1 | | | | | | Expressed in all |
RNF165 | Ring finger protein 165 | | | | | | Tissue enhanced |
HDHD2 | Haloacid dehalogenase-like hydrolase domain containing 2 | | | | | | Expressed in all |
IER3IP1 | Immediate early response 3-interacting protein 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
IER3IP1 | Immediate early response 3 interacting protein 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
SMAD2 | SMAD family member 2 | Cancer-related genes Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
CTIF | CBP80/20-dependent translation initiation factor | | | | | | Expressed in all |
SMAD7 | SMAD family member 7 | Disease related genes Transcription factors
| | | | | Expressed in all |
DYM | Dymeclin | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
RPL17-C18orf32 | RPL17-C18orf32 readthrough | | | | | | Expressed in all |
RPL17 | Ribosomal protein L17 | Plasma proteins Ribosomal proteins
| | | | | Expressed in all |
ACAA2 | Acetyl-CoA acyltransferase 2 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
MYO5B | Myosin VB | Disease related genes Plasma proteins
| | | | | Mixed |
MBD1 | Methyl-CpG binding domain protein 1 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
CXXC1 | CXXC finger protein 1 | Transcription factors
| | | | | Expressed in all |
SKA1 | Spindle and kinetochore associated complex subunit 1 | | | | | | Tissue enhanced |
MAPK4 | Mitogen-activated protein kinase 4 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
ME2 | Malic enzyme 2, NAD(+)-dependent, mitochondrial | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
SMAD4 | SMAD family member 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
POLI | Polymerase (DNA directed) iota | Enzymes
| | | | | Expressed in all |
C18orf54 | Chromosome 18 open reading frame 54 | Predicted secreted proteins
| | | | | Tissue enhanced |
RAB27B | RAB27B, member RAS oncogene family | Plasma proteins
| | | | | Tissue enhanced |
CCDC68 | Coiled-coil domain containing 68 | | | | | | Mixed |
TXNL1 | Thioredoxin-like 1 | Plasma proteins
| | | | | Expressed in all |
ST8SIA3 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | Predicted membrane proteins
| | | | | Tissue enriched |
ONECUT2 | One cut homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
FECH | Ferrochelatase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
NARS | Asparaginyl-tRNA synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
ATP8B1 | ATPase, aminophospholipid transporter, class I, type 8B, member 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
MALT1 | Mucosa associated lymphoid tissue lymphoma translocation gene 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ZNF532 | Zinc finger protein 532 | Transcription factors
| | | | | Expressed in all |
LMAN1 | Lectin, mannose-binding, 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PIGN | Phosphatidylinositol glycan anchor biosynthesis, class N | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
KIAA1468 | KIAA1468 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TNFRSF11A | Tumor necrosis factor receptor superfamily, member 11a, NFKB activator | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |